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 53 
Abstract 54 
Aims: Computed tomographic colonography (CTC) is currently the only whole-colon 55 
screening test for colorectal cancer (CRC) that can offer reduced or non-laxative forms of 56 
bowel preparation. These are likely to be less burdensome for patients compared with full-57 
laxative purgation but may also reduce test sensitivity and specificity. This study explored 58 
the relative value patients place on comfort and convenience vs. test sensitivity and 59 
specificity in the screening context.  60 
Materials and methods: Twenty semi-structured interviews were carried out with patients 61 
attending hospital for radiological tests unrelated to CTC. Preferences for CTC with different 62 
types of bowel preparation for CTC screening were examined and interviews were analysed 63 
thematically. The discussion guide included separate sections on CTC, bowel preparation 64 
methods (non-, reduced- and full-laxative), and sensitivity and specificity. Patients were 65 
given information on each topic in turn and asked about their views and preferences during 66 
each section.  67 
Results: Following information about the test, patients’ attitudes towards CTC were positive. 68 
Following information on bowel preparation, full-laxative purgation was anticipated to cause 69 
more adverse physical and lifestyle effects than using reduced- or non-laxative preparation.  70 
However, stated preferences were approximately equally divided, largely due to patients 71 
anticipating that non-laxative preparations would reduce test accuracy (because the bowel 72 
was not thoroughly cleansed). Following information on sensitivity and specificity (which 73 
supported patients’ expectations), the predominant stated preference was for full-laxative 74 
preparation.  75 
Conclusions: Patients are likely to value test sensitivity and specificity over a more 76 
comfortable and convenient preparation. Future research should test this hypothesis on a 77 
larger sample. 78 
  79 
Introduction 80 
Computed tomographic colonography (CTC) is a relatively novel radiological test for 81 
detecting colorectal cancer (CRC) and precancerous polyps. It has the advantage of being 82 
less invasive than colonoscopy and as such is often preferred by screening participants (1). 83 
CTC has been recommended as a screening test based on data indicating that it achieves 84 
similar sensitivity (the ability to detect disease when it is present) for important colonic 85 
lesions (polyps ≥10mm or cancer) compared to colonoscopy, which is generally accepted to 86 
be the current gold-standard whole-colon examination (2–4). However, CTC has lower 87 
sensitivity for smaller polyps compared with colonoscopy (5) and it has lower specificity (i.e. 88 
disease is more likely to be suspected when it is absent), giving a higher false-positive rate 89 
that results in unnecessary follow-up testing. 90 
A potential benefit of CTC is that it remains the only whole-colon investigation that allows 91 
patients to avoid full-laxative purgation required by other modalities. This may represent a 92 
major advantage because full laxative preparation is often reported to be the worst part of 93 
the entire test experience (6,7) and patients’ experience of reduced-laxative preparations 94 
have been found to be superior compared with full-laxative alternatives (e.g. 8–10). It has 95 
also been argued that offering full-laxative preparation for CTC discourages people from 96 
undergoing the test, therefore reducing uptake and diminishing the population health 97 
benefits (11).   98 
A randomised controlled trial found that screening uptake was significantly higher following 99 
an invitation to undergo CTC with a reduced-laxative preparation than full-laxative 100 
colonoscopy (34% of 982 vs. 22% of 5924 participants; 12). A sub-study on acceptability 101 
found that patients expected the preparation be less burdensome in the CTC arm (13). 102 
However, as both bowel preparation and test varied between trial arms, it is not possible to 103 
be certain that the preparation itself was a specific deterrent to uptake.  104 
The potential downside of reducing the intensity of the laxative component of bowel 105 
preparation is a reduction in test sensitivity and specificity for polyps (14). A small number of 106 
studies have asked respondents to consider both outcome features of the test (such as 107 
sensitivity) and process features (such as discomfort) before stating their preferences and 108 
these studies suggest that patients prioritise ‘accuracy’ over test experience in both 109 
screening and diagnostic contexts (15–17). Furthermore, even relatively small differences in 110 
sensitivity may be considered to be important (18). It is therefore possible that sensitivity and 111 
specificity of CTC would be prioritised over the discomfort and inconvenience of the bowel 112 
preparation if patients were given this information. 113 
Most studies of preferences and acceptability have not mentioned issues of sensitivity and 114 
specificity to participants: A meta-analysis of patients’ preferences for colonoscopy or CTC 115 
after experiencing both tests (1) found that 17 out of 23 studies did not provide any 116 
information on sensitivity. In the remaining studies, participants were informed that both tests 117 
were equally sensitive, despite evidence that CTC has lower sensitivity for smaller pre-118 
cancerous polyps (e.g. 5). No study provided information on specificity directly although 119 
three studies informed patients about a 20% referral rate for colonoscopy after CTC. 120 
Participants in these studies may have made inaccurate assumptions (for example, that the 121 
more recently developed CTC was most sensitive; 16). This lack of information may reflect a 122 
common (but perhaps mistaken) assumption among medical staff that patients value comfort 123 
over accuracy (19,20). 124 
The aim of the present study was therefore to examine patient trade-offs between the 125 
discomfort and inconvenience of the bowel preparation vs. sensitivity and specificity of CTC 126 
in the screening context. We conducted semi-structured interviews in which patients were 127 
asked to consider a hypothetical context where they were offered CTC for screening. We 128 
provided information on three types of bowel preparation (non-, reduced- and full-laxative), 129 
first focusing on the practicalities of each method, and then on their associated sensitivity 130 
and specificity. Patients were asked to express preferences and discuss the reasons for their 131 
choices at each point.  132 
 133 
Materials and Methods 134 
Design and participants 135 
Following ethical approval by an NHS Proportionate Review Sub-committee, a research 136 
assistant identified a consecutive sample of patients scheduled to attend an NHS teaching 137 
hospital radiology department for ultrasonography or radiography for reasons unrelated to 138 
the present study. Once identified, patients were mailed an information sheet and invitation 139 
to participate in a face-to-face interview.  Eligibility criteria were patients aged 45-59 years 140 
(to eliminate effects of prior experience of CRC screening which starts at 60 years in 141 
England); ability to read and speak English; no previous experience of CTC or other colonic 142 
investigations and no personal history of CRC. Patients returning a reply slip expressing 143 
interest were met on the day of their appointment by a research assistant (BLIND FOR 144 
REVIEW) to answer questions, confirm eligibility, and take written consent. Those who 145 
consented took part in a 45-60 minute interview shortly after their test or on another day 146 
depending on their preference and were offered £10 remuneration. 147 
Measures 148 
Semi-structured interviews were carried out with (BLIND FOR REVIEW); patients received 149 
key information in sections in order to monitor preferences at different stages and ensure 150 
that they were not overburdened. The face-to-face nature of the interviews allowed the 151 
interviewer to probe comprehension and provide more detail as necessary. Patients were 152 
also able to ask questions and receive explanations of unfamiliar concepts (particularly 153 
sensitivity and specificity) before responding. Verbal information was supplemented by a 154 
visual presentation (in PowerPoint 2010 for Windows, Microsoft, Redmond, WA, USA) to aid 155 
comprehension. The sections gave information on CRC screening, the percentage of polyps 156 
that may turn into cancer (8% after 10 years; 24% after 20 years), the CTC test procedure, a 157 
set of non-, reduced- and full-laxative preparation characteristics, representative quotes from 158 
patients about their experiences with non- and full-laxative preparations (taken from a 159 
previous interview study; 21) and the implications of how preparation affects sensitivity 160 
(86%; 89%; 92% respectively) and specificity (89%; 90%; 91%) for pre-cancerous polyps. 161 
The order in which each preparation was presented was determined randomly for each 162 
participant to counteract possible order effects. Information was derived from the existing 163 
literature (22–30) and local CTC information sheets developed by psychologists and 164 
radiologists with experience in the area. 165 
After each section, patients were asked questions based on a prepared discussion guide 166 
(Tables 1-4).  Age, gender, health and employment status were noted. After information on 167 
CRC screening and CTC, patients were asked about perceived benefits and barriers 168 
towards the test, and their willingness to have it in principle if it were offered in the next 169 
month. This was followed with information on the practicalities of each method of bowel 170 
preparation, after which patients were asked about expected physical and lifestyle effects. 171 
They were also asked how they thought the preparations might affect the test (giving them 172 
an opportunity to suggest that there might be differences in terms of sensitivity or specificity) 173 
and their overall preferences. Information was then given on sensitivity, and patients were 174 
asked about their impressions of this attribute and asked to consider their preferred 175 
preparation again. They were also asked about their preferred preparation after receiving 176 
information on colonoscopy (as the follow-up test that would be recommended if an 177 
abnormality was suspected on CTC) and specificity (i.e. the possibility of false positives on 178 
CTC that result in an unnecessary colonoscopy), as well as being asked about their 179 
impressions of these aspects of testing. In the concluding section of the interview, patients 180 
were asked about their overall impressions of CTC and their willingness to attend for 181 
screening. 182 
Analysis 183 
Recordings were transcribed and a thematic analysis carried out (31). Qualitative research 184 
software (NVivo 9 for Windows, QSR International, Cambridge, MA, USA) was used to read 185 
participants’ responses repeatedly and categorise them based on a framework 186 
corresponding to the typical order of the interview (i.e. initial views of CTC, preparation 187 
impressions and preferences after information on practicalities, sensitivity, specificity and 188 
final views of CTC). Similar responses were grouped in order to detect common themes and 189 
determine participants’ preferences within each section of the interview. 190 
  191 
Results 192 
Demographics 193 
Participants (n=20, 11 males) had a mean age of 52 years (range: 45-58 years) and 13 were 194 
in full- or part-time paid employment.  Sixteen reported their health quality to be good or fair. 195 
Data on education and socioeconomic status were not collected. At the start of the interview, 196 
participants often considered their existing knowledge of CRC or screening to be poor (“I 197 
don’t really know anything about screening”; male, 47). However, other participants often 198 
referred to possible aims of screening (prevention and early detection) or established 199 
screening programmes (“I’ve always had a smear test dead on time, I’ve always had breast 200 
cancer screening on time…I would think [the aim of CRC screening], like most screenings, is 201 
to diagnose early, because the earlier diagnosed, the better chance you’ve got and to put 202 
people’s mind at rest as well”; female, 54).  203 
Initial attitudes towards CTC screening 204 
After learning about the practicalities of CTC and having the opportunity to ask questions, 205 
patients were generally positive towards the test, citing factors such as the potential to 206 
provide reassurance (“Be nice to have…satisfy myself that I’ve got no problems”; male, 54 207 
years), a personal sense of risk and the potential to prevent cancer (“I think as you get older, 208 
I think possibly it pays for you to look after your health and prevention is better than cure”; 209 
male, 56 years). There were some factors that diminished the perceived acceptability such 210 
as possible scheduling difficulties, perceived low risk of CRC (“I suppose I would query the 211 
likelihood that it was relevant to me”; male, 54 years) and concerns about risks associated 212 
with the procedure (“I would definitely give myself a few days, loads of ‘Google-ling’ to find 213 
more information…looking at the risk of the scanning itself, looking at alternatives”; male, 49 214 
years). 215 
Preparation preferences after information on practicalities 216 
After receiving information on practicalities for each method of preparation, patients 217 
perceived an apparent ordering in terms of physical effects. Non-laxative preparation was 218 
expected to cause fewer adverse effects than reduced-laxative preparation and both were 219 
perceived as more manageable than more full-laxative preparation (“If the only effect the 220 
[non-laxative preparation] has is to change the colour of the stool…I don’t see how you’d 221 
have any ill effects”; male, 46 years). Full-laxative preparation was expected to cause the 222 
most frequent and inconvenient physical effects including diarrhoea, increased bowel 223 
frequency, urgency, cramping, dehydration and fatigue (“You have a powerful laxative and 224 
you’re suffering from diarrhoea, you’re going to feel pretty weak, aren’t you?”; male, 56 225 
years).  Physical effects from dietary restrictions were expected to be minor in comparison 226 
and were generally anticipated to be an issue for reduced- and full-laxative preparations 227 
only. 228 
Non-laxative preparation was expected to cause some disruption to daily routine. This was 229 
related primarily to work issues such as transporting medicine to the workplace, storing it 230 
there and with how other colleagues would respond to it (“If I, unfortunately, found myself 231 
with clients, for example, I might find it more difficult…I wouldn’t want to get my special 232 
preparation out at the lunch table”; male, 45 years). 233 
The main lifestyle effects anticipated for reduced- and full-laxative preparations related to 234 
change in bowel habit. This was expected to cause some slight disruption to social and 235 
working life in the case of the former (“If you’re basically caught short with no toilet, that’s the 236 
obvious one”; male, 47 years). The latter was expected to cause the most significant lifestyle 237 
changes (“I’d probably stay home for the day. Yes, I wouldn’t want to go out”; male, 46 238 
years). Full-laxative preparation was also expected to make travelling difficult.  As with 239 
anticipated physical effects, the effects of dietary restrictions were expected to be less 240 
disruptive to lifestyle than the effects of change in bowel habit. 241 
Despite this ordering of tolerability, when patients were asked to state their preferred 242 
preparation (if any), opinion was divided among the three options. Those stating a 243 
preference for reduced- or full-laxative preparations often asked about or guessed that there 244 
were differences in accuracy between preparations (“Say if your colon is a lot clearer, you’ll 245 
be able to detect a lot more, that’s what I’m thinking…‘cause it’s clear of any debris”; female, 246 
54 years). At this stage, some patients viewed a reduced-laxative preparation as a good 247 
compromise between convenience and the anticipated effect on the test performance.   248 
Preparation preferences after information on sensitivity  249 
After receiving information on sensitivity, patients perceived it to be a key attribute and 250 
explained their view both in terms of providing greater reassurance that no pre-cancerous 251 
polyps had been missed (“If you want to have your bowel completely looked at, including 252 
polyps you’re going to have to choose the one that shows everything or what’s the point in 253 
having it? There’s no point in half doing it, you’ve got to have it done completely for peace of 254 
mind”; female, 54 years) and the harmful consequences of a false negative (“How would you 255 
feel if you settled for, say, the lowest one, [non-laxative preparation] and took that and they 256 
came back and said ‘no, you’re all clear’ and then two years down the line, bang, ‘oh, you’ve 257 
got bowel cancer’?”; male, 56 years). There was a clear overall preference for full-laxative 258 
preparation at this stage. Notably, several patients appreciated that the differences were 259 
small but still regarded them as important (“it doesn’t look statistically particularly much of a 260 
difference but I would probably put my money on [full-laxative preparation], then…just 261 
subjectively I would feel better about that”; female, 58 years). 262 
Interestingly, some patients reasoned that against the background of undergoing the test, 263 
the differences between preparations would be minimal in terms of overall inconvenience (“If 264 
you’re going through all that hassle in some ways to actually have the test, then you might 265 
as well get the most out of it. So, that’s why I would possibly change back to [full-laxative 266 
preparation]”; male, 55 years). Few participants expressed a preference for a less intensive 267 
preparation at this stage and most cited external barriers (such as travel) as the reason for 268 
their preference.   269 
Preparation preferences after information on specificity 270 
As part of the discussion guide, we also sought to identify views on false positives. After 271 
receiving information on these attributes, patients generally had a negative view of 272 
colonoscopy as a follow-up test, particularly in relation to issues around dignity and 273 
invasiveness; these represented reasons to value specificity (“I would really hate to have an 274 
unnecessary colonoscopy…The sort of invasiveness of machines on the body, and I feel 275 
that always is very hard”; female, 49 years). They were also concerned about anxiety 276 
associated with an abnormal test result (“Emotionally…cancer’s a big sort of, like, no-no with 277 
some people…you wouldn’t want to go down the route of…a false alarm, which is not only 278 
upsetting to you, it’s upsetting to people around you who think they’re going to lose you”; 279 
male, 56 years). 280 
As with sensitivity, there was a clear overall preference for full-laxative preparation in terms 281 
of specificity; patients considered it worth undergoing in order to reduce the risk of a false 282 
alarm (“If you’ve got [full-laxative preparation] done, you stand a better chance of not being 283 
called back…Yeah, [full-laxative preparation] seems to be the one that would give you more 284 
peace of mind…so, obviously then, looking at that, it’s essential that you use a laxative so 285 
the medical staff can see every single thing”; female, 58 years). 286 
Final attitudes towards CTC 287 
After receiving all information at the end of the interview, participants generally felt that they 288 
would be willing to have CTC for screening (“I don’t see any reason not to have it. I mean it 289 
seems to me, if that were routine it would be fine”; female, 56). Several participants 290 
remained ambivalent about accepting any kind of CTC, particularly if they felt that CRC was 291 
not as serious as other cancers or they did not consider themselves to be at high risk (“I 292 
think it’s one of those things that’s definitely, definitely manageable if you know you’re 293 
supposed to be having it done but not the sort of thing you’re going to volunteer to have 294 
without good cause”; male, 47).However, there was no clear change in willingness to have 295 
CTC compared to participants’ initial attitudes (“I think at the start…I was pretty confident I 296 
would take up the offer, unless I found out something that would put me off but nothing I’ve 297 
found out today has put me off”; male, 46). 298 
 299 
Discussion 300 
These findings support other evidence that potential screening participants value sensitivity 301 
and specificity highly in test decisions (15–18). Although full-laxative preparation was 302 
expected to cause more adverse physical and lifestyle effects, patients felt they were 303 
prepared to accept this additional inconvenience and discomfort in order to maximise the 304 
benefits of testing and reduce the risk of harm. It was notable that patients were influenced 305 
by even small differences in specificity and, in particular, sensitivity for polyps even though 306 
they were informed that most polyps do not become cancers. These findings contribute to a 307 
growing body of evidence suggesting that outcome features are valued over process 308 
features in the screening and diagnostic contexts, in contrast with clinicians’ assumptions 309 
(19,20).  310 
It has been argued that uptake of screening CTC may be optimised through the use of less 311 
burdensome reduced-laxative preparations instead of standard full-purgation methods (11). 312 
This reasoning was behind the decision to offer reduced-laxative preparation in a 313 
randomised trial of screening CTC vs. colonoscopy (12). Our results support the trial findings 314 
that non- and reduced-laxative preparations are perceived as more acceptable in terms of 315 
the direct patient experience (10), but they suggest that reduced-laxative preparations may 316 
ultimately run counter to patient’ preferences if they also reduce sensitivity or specificity. If 317 
the present results are confirmed, it may be necessary for policy-makers and researchers to 318 
consider whether full-laxative preparations would be both more clinically advantageous and 319 
more consistent with patients’ priorities, or perhaps give patients a choice.  320 
It should be noted that this study was based on the premise that an increase in tolerability is 321 
associated with a decrease in sensitivity and specificity (14). However, the choice of 322 
preparation would be clear for all stakeholders if it were possible to offer a superior patient 323 
experience and optimised sensitivity and specificity simultaneously. Although this study 324 
assessed perceptions of just three preparations, using estimates of their sensitivity and 325 
specificity, many other regimens exist and there is considerable uncertainty regarding the 326 
performance characteristics of such a diverse range (3). It is possible that alternative 327 
preparations (perhaps developed in the future) would not require patients to compromise to 328 
the same extent, if at all. Future research should aim to reduce these uncertainties and 329 
determine whether a fully optimised preparation can be achieved. 330 
Our findings regarding preparation preferences should also be put in the broader context of 331 
perceptions of CTC and CRC screening: In our interviews, the value of the test itself and 332 
factors such as perceived low risk of CRC were more significant barriers than the 333 
preparation, suggesting that strategies to address these issues may be more effective at 334 
optimising uptake overall than the choice of preparation. 335 
This study has limitations. It was small-scale and exploratory, and therefore larger studies, in 336 
other settings, are needed to confirm the findings. It is also possible that statistics on 337 
sensitivity and specificity were particularly impactful on preferences because of the study 338 
design in which the three types of preparation were presented in parallel, which may have 339 
emphasised differences. A more naturalistic design in which only one method is described 340 
without the reference points provided by alternatives, may find that participants focus on test 341 
specificity and sensitivity to a lesser degree. The most robust validation of these findings 342 
would be to evaluate actual screening behaviour outside of a hypothetical context.  343 
Conclusion  344 
The results of this study suggest that when given appropriate information, patients favour 345 
methods of preparation for CTC screening that maximise test sensitivity and specificity and 346 
thereby increase the chance of health benefits and reduce the need for further testing.  This 347 
suggests that patients attach greater priority to getting the best test than getting the best test 348 
experience. 349 
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Tables and figures 436 
 437 
Key information on CRC screening 
 Aims to detect CRC early, when it is more treatable 
Aims to prevent CRC cancer, through detection and removal of pre-cancerous polyps 
8 out of 100 polyps become cancers after 10 years; 24 out of 100 after 20 years 
 
Key information on CTC 
    Involves two scans being taken and read by a specially-trained doctor 
    Scanning is preceded by injections (muscle relaxant, intravenous dye) and rectal insufflation with gas 
    Testing takes 20-30 minutes 
    Carries a risk of radiation-induced cancer (same risk as smoking 140 cigarettes) 
    Carries a risk of a hole in the bowel wall (1 in 3,000) 
    Usually, results cannot be given on the same day 
    A follow-up test (colonoscopy) would be needed to assess/remove suspected abnormalities 
Table 1. showing key information on CRC screening and CTC 438 
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Key information on non-, reduced- & full-laxative preparation 
 Non-laxative preparation 
  Medicine: Powdered barium would be mixed with water and drunk with food three times a day on 
the two days before CTC while the mixture is kept in the fridge 
  Effects: This medicine is not a laxative but may turn stools pale 
  Diet: People would have to go without high fibre foods from two days before CTC until four hours 
before, after which no solid food could be eaten 
 Reduced-laxative preparation 
  Medicine: Liquid iodine would be mixed with water and cordial and drunk on the two evenings 
before CTC 
  Effects: This medicine is a mild laxative and carries a 1 in 250,000 risk of serious allergic reaction 
  Diet: People would have to go without high fibre foods from two days before CTC until one day 
before, after which no solid food could be eaten 
 Full-laxative preparation 
  Medicine: “Picolax” powder would be mixed with hot water and drunk on the morning and 
afternoon before CTC 
  Effects: This medicine is a powerful laxative 
  Diet: People would have to go without high fibre foods from two days before CTC until the day of 
the test and go without snacking between meals or supper on the day before CTC 
Table 2. showing key information on preparation practicalities 450 
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Representative quotes from patients’ experiences with non and full-laxative preparation (21) 
 Non-laxative preparation 
  Diet: “You had to go on a light fibre diet so that meant no fruit or vegetables, no red meat, no 
whole meal bread, no porridge…That was a bit hard for me because I eat a lot of food with fibre" 
(female, 76) 
“You couldn’t eat any meat, which was not a big problem, I can eat meat or leave it alone...there 
was no vegetable or fruit…I could have poached eggs…It was just not what I would eat on a 
normal day but it was OK. It was bearable...It wasn’t too much of a hardship" (female, 78) 
  Medicine: “I had to drink [the mixture] three times a day…Morning, afternoon and evening…I 
didn’t like it, of course. Well you don’t like drinking that stuff. It says in the notes that it has a 
pleasant taste but…it’s not really all that pleasant” (female, 76) 
"I had to drink this [mixture]…I didn’t find that in any way strenuous…It wasn’t too bad at all…I 
just drank it down and it made my mouth a bit dry but other than that it was alright”  (female 78) 
 Full-laxative preparation 
  Diet: “You pretty well starve while you’re on this horrible stuff” (female, 79) 
“I managed all that…I just kept to the letter by not eating any solids on the day before and the 
day previous to that, I had made sure there was no fibre in my diet” (male, 76) 
  Medicine: “Pretty, pretty awful. I didn’t go to work that day ‘cause I was running to the toilet…I 
couldn’t have been at work, the toilet at work is down the stairs so you could never make it in 
time” (female, 69) 
“It was very effective, you know, but then I expected it...I didn’t enjoy it particularly. It was 
necessary” (female, 81) 
Table 3. showing quotes describing patients’ experiences with non- and full-laxative preparation 460 
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Key information on differences in sensitivity between preparations 
 If 100 people with polyps had a particular preparation: 
  86 would have their polyps found after non-laxative preparation 
  89 would have their polyps found after reduced-laxative preparation 
  92 would have their polyps found after full-laxative preparation 
Key information on follow-up colonoscopy 
    Involves a small tube with a camera being passed through the bowel 
    The camera takes pictures that a doctor can see on a screen 
    Colonoscopy is preceded by injection of a muscle relaxant, painkiller and a sedative 
    Testing takes 30 minutes plus an hour for the sedative to wear off 
    Carries a risk of bleeding (1 in 150) and a hole in the bowel wall (1 in 1,000) 
    Can take samples and remove polyps 
Key information on differences in specificity between preparations 
 If 100 people without polyps had a particular preparation:  
  11 would have an unnecessary colonoscopy after non-laxative preparation 
  10 would have an unnecessary colonoscopy after reduced-laxative preparation 
    9 would have an unnecessary colonoscopy after full-laxative preparation 
Table 4. showing key information on sensitivity, colonoscopy and specificity 470 
